Tags

Type your tag names separated by a space and hit enter

Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Ophthalmic Res 2007; 39(2):69-75OR

Abstract

In glaucoma, retinal ganglion cell (RGC) death is induced by many risk factors, including ocular hypertension. It has been proposed that glutamate-mediated oxidative stress may also contribute to this RGC death. Cannabinoids are known to possess therapeutic properties including ocular hypotension and antioxidation. In this study, we test the hypothesis that (-)Delta(9)-tetrahydrocannabinol (THC) lowers intraocular pressure (IOP) and prevents RGC death in a rat model of glaucoma. Arat model of experimental glaucoma with chronic, moderately elevated IOP was produced unilaterally by cauterization of episcleral vessels. Rats received weekly injections of THC at a level of 5 mg/kg or vehicle for 20 weeks. IOP of both eyes was measured weekly on anesthetized animals immediately before THC treatment. RGCs were labeled in a retrograde fashion and counted in whole-mounted retinas. IOP was elevated in all operated eyes 1 day after the operation and remained elevated in the vehicle-treated rats throughout 20 weeks. In THC-treated rats, IOP elevation in operated eyes was diminished 2 weeks after operation and remained reduced. IOP in the contralateral control eyes was not affected by THC. In the operated eyes of vehicle-treated animals, there was a loss of approximately 50 and 40% of the RGCs in the peripheral and central retina, respectively. The RGC loss in the operated eyes of the THC-treated animals was reduced to 10-20%. These results demonstrate that THC is a neuroprotectant that preserves RGCs in an experimental model of glaucoma, possibly through a reduction in IOP.

Authors+Show Affiliations

Department of Ophthalmology, Medical College of Georgia, Augusta, GA 30912, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17284931

Citation

Crandall, James, et al. "Neuroprotective and Intraocular Pressure-lowering Effects of (-)Delta9-tetrahydrocannabinol in a Rat Model of Glaucoma." Ophthalmic Research, vol. 39, no. 2, 2007, pp. 69-75.
Crandall J, Matragoon S, Khalifa YM, et al. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Ophthalmic Res. 2007;39(2):69-75.
Crandall, J., Matragoon, S., Khalifa, Y. M., Borlongan, C., Tsai, N. T., Caldwell, R. B., & Liou, G. I. (2007). Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Ophthalmic Research, 39(2), pp. 69-75.
Crandall J, et al. Neuroprotective and Intraocular Pressure-lowering Effects of (-)Delta9-tetrahydrocannabinol in a Rat Model of Glaucoma. Ophthalmic Res. 2007;39(2):69-75. PubMed PMID: 17284931.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. AU - Crandall,James, AU - Matragoon,Suraporn, AU - Khalifa,Yousuf M, AU - Borlongan,Caesar, AU - Tsai,Nai-Tse, AU - Caldwell,Ruth B, AU - Liou,Gregory I, Y1 - 2007/02/02/ PY - 2006/03/17/received PY - 2006/09/14/accepted PY - 2007/2/8/pubmed PY - 2007/5/11/medline PY - 2007/2/8/entrez SP - 69 EP - 75 JF - Ophthalmic research JO - Ophthalmic Res. VL - 39 IS - 2 N2 - In glaucoma, retinal ganglion cell (RGC) death is induced by many risk factors, including ocular hypertension. It has been proposed that glutamate-mediated oxidative stress may also contribute to this RGC death. Cannabinoids are known to possess therapeutic properties including ocular hypotension and antioxidation. In this study, we test the hypothesis that (-)Delta(9)-tetrahydrocannabinol (THC) lowers intraocular pressure (IOP) and prevents RGC death in a rat model of glaucoma. Arat model of experimental glaucoma with chronic, moderately elevated IOP was produced unilaterally by cauterization of episcleral vessels. Rats received weekly injections of THC at a level of 5 mg/kg or vehicle for 20 weeks. IOP of both eyes was measured weekly on anesthetized animals immediately before THC treatment. RGCs were labeled in a retrograde fashion and counted in whole-mounted retinas. IOP was elevated in all operated eyes 1 day after the operation and remained elevated in the vehicle-treated rats throughout 20 weeks. In THC-treated rats, IOP elevation in operated eyes was diminished 2 weeks after operation and remained reduced. IOP in the contralateral control eyes was not affected by THC. In the operated eyes of vehicle-treated animals, there was a loss of approximately 50 and 40% of the RGCs in the peripheral and central retina, respectively. The RGC loss in the operated eyes of the THC-treated animals was reduced to 10-20%. These results demonstrate that THC is a neuroprotectant that preserves RGCs in an experimental model of glaucoma, possibly through a reduction in IOP. SN - 0030-3747 UR - https://www.unboundmedicine.com/medline/citation/17284931/abstract/Neuroprotective_and_Intraocular_Pressure_Lowering_Effects_of____Delta_Tetrahydrocannabinol_in_a_Rat_Model_of_Glaucoma L2 - https://www.karger.com?DOI=10.1159/000099240 DB - PRIME DP - Unbound Medicine ER -